Diagnosis and Treatment of Human Papillomavirus-Positive Oropharyngeal Cancer
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 August 2020) | Viewed by 103
Special Issue Editor
Interests: oropharyngeal cancer; human papilloma virus; p16; American Joint Committee on Cancer Eighth Edition; robotic surgery; cetuximab; de-escalation; immune checkpoint inhibitors; vaccine
Special Issue Information
Dear Colleagues,
Human papillomavirus (HPV) is one of the most important biomarkers of squamous cell carcinoma of the head and neck (SCCHN). The incidence of HPV-positive oropharyngeal cancer is rapidly increasing in the world. HPV-positive oropharyngeal cancers are distinct from other SCCHN in terms of biology, morphology, and prognosis. One of the major novelties introduced in the eighth edition of the American Joint Committee on Cancer is a diagnostic algorithm for p16-positive oropharyngeal carcinoma. In this Special Issue, we would like to focus on diagnosis and treatment strategies for HPV-positive oropharyngeal cancer. Papers are welcomed regarding the pathogenesis, molecular diagnosis, and multimodal treatments for HPV-positive oropharyngeal cancer. Novel treatment developments may include robotic surgery, de-escalation strategies using anti-EGFR-targeted therapy, immune checkpoint inhibitors, vaccine, and new targeted therapies.
Dr. Tomoya Yokota
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Oropharyngeal cancer
- Human papilloma virus
- p16
- American Joint Committee on Cancer Eighth Edition
- Robotic surgery
- Cetuximab
- De-escalation
- Immune checkpoint inhibitors
- Vaccine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
